Tomasz Wandtke
- Humanized S.typhi flagellin (FliC) transfected non-small cell lung cancer (NSCLC) cells induce local inflammatory and necrotic changes in an experimental modelBy Marek Jankowski, Janusz Kowalewski, Tomasz Wandtke, Robert Lenartowski, Piotr Kopinski, Maciej Dancewicz and Tomasz TyrakowskiMarek Jankowski1Dept of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandJanusz Kowalewski2Dept of Thorax and Tumor Surgery, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandTomasz Wandtke1Dept of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandRobert Lenartowski3Dept of Clinical Pathobiochemistry, Nicolaus Copernicus University, Bydgoszcz, PolandPiotr Kopinski1Dept of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandMaciej Dancewicz2Dept of Thorax and Tumor Surgery, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandTomasz Tyrakowski4Dept of Clinical Pathobiochemistry and Chemistry, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland
- Mechanisms of impaired immune surveillance in lower airways of smokers. Data from bronchoalveolar lavage (BAL) harvested in selected interstitial lung diseases (ILDs) and control groupBy Piotr Kopinski, Andrzej Dyczek, Grzegorz Przybylski, Barbara Balicka-Slusarczyk, Agnieszka Jarzemska, Tomasz Wandtke, Ewelina Pόlgesek and Magda IgielskaPiotr Kopinski1Dept of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandAndrzej Dyczek2II Dept of Internal Medicine, Centre of Immunological Diseases, Collegium Medicum, Jagiellonian University, Krakόw, PolandGrzegorz Przybylski3Dept of Lung Diseases and Tuberculosis, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandBarbara Balicka-Slusarczyk4Dept of Toxicology and Environmental Diseases, Collegium Medicum, Jagiellonian University, Krakόw, PolandAgnieszka Jarzemska3Dept of Lung Diseases and Tuberculosis, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandTomasz Wandtke1Dept of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandEwelina Pόlgesek1Dept of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandMagda Igielska1Dept of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland
- Intratumoral injection of plasmid-encoded flagellin inhibits growth of NSCLC-cells in murine lung cancer modelBy Marek Jankowski, Tomasz Wandtke, Robert Lenartowski, Olga Haus and Piotr KopinskiMarek Jankowski1Gene Therapy, Nicolaus Copernicus University, Bydgoszcz, PolandTomasz Wandtke1Gene Therapy, Nicolaus Copernicus University, Bydgoszcz, PolandRobert Lenartowski3Genetics, Nicolaus Copernicus University, Torun, PolandOlga Haus2Clinical Genetics, Nicolaus Copernicus University, Bydgoszcz, PolandPiotr Kopinski1Gene Therapy, Nicolaus Copernicus University, Bydgoszcz, Poland
- The death receptors (DRs) expressed on alveolar lymphocytes (AL) in interstitial lung diseases (ILD) participate in apoptosis regulationBy Andrzej Dyczek, Barbara Balicka-Slusarczyk, Jerzy Szczeklik, Grzegorz Przybylsski, Agnieszka Jarzemska, Karina Szablowska, Tomasz Wandtke and Piotr KopinskiAndrzej Dyczek1Dept of Internal Medicine, Centre of Immunological Diseases, Collegium Medicum, Jagiellonian University, Krakow, PolandBarbara Balicka-Slusarczyk2Dept of Toxicology and Environmental Diseases, Collegium Medicum, Jagiellonian University, Kraków, PolandJerzy Szczeklik2Dept of Toxicology and Environmental Diseases, Collegium Medicum, Jagiellonian University, Kraków, PolandGrzegorz Przybylsski3Dept of Lung Diseases @ Tumors, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandAgnieszka Jarzemska3Dept of Lung Diseases @ Tumors, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandKarina Szablowska4Dept of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandTomasz Wandtke4Dept of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandPiotr Kopinski4Dept of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland
- Expression of interleukin-27 (IL27) in human lower airways. Pathophysiological implications in pulmonary sarcoidosis (PS)By Piotr Kopinski, Tomasz Wandtke, Joanna Chorostowska-Wynimko, Grzegorz Przybylski, Ewelina Pólgesek and Andrzej DyczekPiotr Kopinski1Dept. of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandTomasz Wandtke1Dept. of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandJoanna Chorostowska-Wynimko2Laboratory of Molecular Diagnostics and Immunology, Institute of Tuberculosis and Lung Diseases, Warszawa, PolandGrzegorz Przybylski3Dept. of Lung Diseases and Tuberculosis, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandEwelina Pólgesek1Dept. of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandAndrzej Dyczek2Laboratory of Molecular Diagnostics and Immunology, Institute of Tuberculosis and Lung Diseases, Warszawa, Poland
- Hepatocyte growth factor (HGF) expression in bronchoveolar lower (BAL) does not confirm its anti-fibrotic activity in interstitial lung diseases (ILD)By Piotr Kopinski, Joanna Chorostowska-Wynimko, Andrzej Dyczek, Teresa Iwaniec, Ada Rozy, Paulina Jagus, Karina Szablowska, Tomasz Wandtke and Barbara Balicka-SlusarczykPiotr Kopinski1Dept of Gene Therapy, Collegium Medicum, Nikolaus Copernicus University, Bydgoszcz, PolandJoanna Chorostowska-Wynimko2Lab of Molecular Biology and Immunology, Institute of Tuberculosis and Lung Diseases, Warszawa, PolandAndrzej Dyczek3Dept of Internal Medicine, Collegium Medicum, Jagiellonian University, Krakow, PolandTeresa Iwaniec3Dept of Internal Medicine, Collegium Medicum, Jagiellonian University, Krakow, PolandAda Rozy2Lab of Molecular Biology and Immunology, Institute of Tuberculosis and Lung Diseases, Warszawa, PolandPaulina Jagus2Lab of Molecular Biology and Immunology, Institute of Tuberculosis and Lung Diseases, Warszawa, PolandKarina Szablowska1Dept of Gene Therapy, Collegium Medicum, Nikolaus Copernicus University, Bydgoszcz, PolandTomasz Wandtke1Dept of Gene Therapy, Collegium Medicum, Nikolaus Copernicus University, Bydgoszcz, PolandBarbara Balicka-Slusarczyk4Dept of Environmental Diseases and Toxicology, Collegium Medicum, Jagiellonian University, Krakow, Poland
- Interleukin 27 (IL27): A new tool for lung cancer gene immunotherapy?By Tomasz Wandtke, Marek Jankowski, Piotr Kopinski, Mariusz Bella, Janusz Kowalewski, Adam Szpechcinski and Ewelina PólgesekTomasz Wandtke1Dept. of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandMarek Jankowski1Dept. of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandPiotr Kopinski1Dept. of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandMariusz Bella2Dept. of Chest and Tumor Surgery, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandJanusz Kowalewski2Dept. of Chest and Tumor Surgery, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandAdam Szpechcinski3Laboratory of Molecular Diagnostics and Immunology, Institute of Tuberculosis and Lung Diseases, Warszawa, PolandEwelina Pólgesek1Dept. of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland
- Alveolar lymphocytes (AL) produce interleukin 27 (IL27), antigen presenting cell-secreted cytokine. Increased expression of IL27 in bronchoalveolar lavage (BAL) of pulmonary sarcoidosis (PS) patientsBy Tomasz Wandtke, Joanna Chorostowska-Wynimko, Adam Szpechcinski, Grzegorz Przybylski, Agnieszka Jarzemska, Ewelina Wedrowska, Agata Gizycka, Joanna Wielikdzien and Piotr KopinskiTomasz Wandtke1Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandJoanna Chorostowska-Wynimko2Laboratory of Molecular Diagnostics and Immunology, Institute of Tuberculosis and Lung Diseases, Warsaw, PolandAdam Szpechcinski2Laboratory of Molecular Diagnostics and Immunology, Institute of Tuberculosis and Lung Diseases, Warsaw, PolandGrzegorz Przybylski3Lung Diseases and Tuberculosis, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandAgnieszka Jarzemska3Lung Diseases and Tuberculosis, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandEwelina Wedrowska1Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandAgata Gizycka1Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandJoanna Wielikdzien1Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandPiotr Kopinski1Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland
- Interleukin 27 (IL27) as a novel therapeutic tool in lung cancer immune therapyBy Tomasz Wandtke, Marek Jankowski, Ewelina Wedrowska, Karina Szablowska, Joanna Golinska, Joanna Wielikdzien, Janusz Kowalewski and Piotr KopinskiTomasz Wandtke1Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandMarek Jankowski1Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandEwelina Wedrowska1Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandKarina Szablowska1Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandJoanna Golinska1Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandJoanna Wielikdzien1Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandJanusz Kowalewski2Chest and Tumor Surgery, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandPiotr Kopinski1Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland
- Interferon γ (IFNγ) decreases apoptosis rate of antigen primed T helper lymphocytes from bronchoalveolar lavage (BAL)By Piotr Kopinski, Joanna Chorostowska-Wynimko, Andrzej Dyczek, Barbara Balicka-Slusarczyk, Ewelina Pólgesek, Adriana Rozy, Teresa Iwaniec and Tomasz WandtkePiotr Kopinski1Dept of Gene Therapy, Collegium Medicum, Nicolaus Copernicus, Bydgoszcz, PolandJoanna Chorostowska-Wynimko2II Dept. of Internal Medicine, Center of Immunological Diseases, Collegium Medicum, Jagiellonian University, Krakow, PolandAndrzej Dyczek3Dept. of Molecular Biology and Immunology, Inst. of Tuberculosis and Lung Diseases, Warszawa, PolandBarbara Balicka-Slusarczyk4Dept of Toxicology and Environmental Diseases, Collegium Medicum, Jagiellonian University, Krakow, PolandEwelina Pólgesek1Dept of Gene Therapy, Collegium Medicum, Nicolaus Copernicus, Bydgoszcz, PolandAdriana Rozy2II Dept. of Internal Medicine, Center of Immunological Diseases, Collegium Medicum, Jagiellonian University, Krakow, PolandTeresa Iwaniec3Dept. of Molecular Biology and Immunology, Inst. of Tuberculosis and Lung Diseases, Warszawa, PolandTomasz Wandtke1Dept of Gene Therapy, Collegium Medicum, Nicolaus Copernicus, Bydgoszcz, Poland
- Decreased apoptosis rate of alveolar lymphocytes (AL) in patients with stage I-IIA non-small cell lung cancer (NSCLC)By Agata Gizycka, Joanna Chorostowska-Wynimko, Cezary Rybacki, Andrzej Dyczek, Tomasz Wandtke and Piotr KopinskiAgata Gizycka1Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandJoanna Chorostowska-Wynimko1Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandCezary Rybacki2Pulmonology and Allergy Clinical Ward, 10 Military Research Hospital and Polyclinic, Bydgoszcz, PolandAndrzej Dyczek3II Department of Internal Medicine, Centre of Immunological Diseases, Collegium Medicum, Jagiellonian University, Cracow, PolandTomasz Wandtke4Department of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandPiotr Kopinski4Department of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland
- Increased expression of WSX1 on alveolar lymphocytes (AL) in patients with early stage non-small cell lung cancer (NSCLC). Preliminary reportBy Tomasz Wandtke, Joanna Wielikdzien, Cezary Rybacki, Grzegorz Przybylski, Joanna Golinska, Blazej Przybyslawski and Piotr KopinskiTomasz Wandtke1Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandJoanna Wielikdzien1Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandCezary Rybacki2Internal Medicine and Diabetes Clinical Ward, 10th Military Research Hospital and Policlinic, Bydgoszcz, PolandGrzegorz Przybylski3Lung Diseases and Tuberculosis, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandJoanna Golinska1Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandBlazej Przybyslawski2Internal Medicine and Diabetes Clinical Ward, 10th Military Research Hospital and Policlinic, Bydgoszcz, PolandPiotr Kopinski1Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland
- Evaluation of predictive and therapeutic value of WSX1/IL27 axis in non-small cell lung cancer (NSCLC)By Tomasz Wandtke, Joanna Wozniak, Piotr Kopinski, Joanna Chorostowska-Wynimko, Teresa Iwaniec and Andrzej DyczekTomasz Wandtke1Gene Therapy, Nicolaus Copernicus University in Torun, Bydgoszcz, PolandJoanna Wozniak1Gene Therapy, Nicolaus Copernicus University in Torun, Bydgoszcz, PolandPiotr Kopinski1Gene Therapy, Nicolaus Copernicus University in Torun, Bydgoszcz, PolandJoanna Chorostowska-Wynimko2Laboratory of Molecular Diagnostics and Immunology, Institute of Tunerculosis and Lung Diseases, Warsaw, PolandTeresa Iwaniec3II Dept. of Internal Medicine, Collegium Medicum, Jagiellonian University, Krakow, PolandAndrzej Dyczek4The Cardiology Outpatient Clinic, John Paul II Hospital, Krakow, Poland
- Alvolar lymphocytes (AL) in patients with non-small cell lung cancer (NSCLC). Data from tumor-affected lobeBy Joanna Wozniak, Tomasz Wandtke, Piotr Kopinski, Joanna Chorostowska, Agata Gizycka, Cezary Rybacki, Iwona Patyk, Blazej Przybyslawski and Andrzej RedziakJoanna Wozniak1Gene Therapy, Collegium Medicum Nicolaus Copernicus University, Bydgoszcz, PolandTomasz Wandtke1Gene Therapy, Collegium Medicum Nicolaus Copernicus University, Bydgoszcz, PolandPiotr Kopinski1Gene Therapy, Collegium Medicum Nicolaus Copernicus University, Bydgoszcz, PolandJoanna Chorostowska2Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandAgata Gizycka2Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, PolandCezary Rybacki3Dept of Pulmonology and Allergology, 10th Military Hospital, Bydgoszcz, PolandIwona Patyk3Dept of Pulmonology and Allergology, 10th Military Hospital, Bydgoszcz, PolandBlazej Przybyslawski3Dept of Pulmonology and Allergology, 10th Military Hospital, Bydgoszcz, PolandAndrzej Redziak1Gene Therapy, Collegium Medicum Nicolaus Copernicus University, Bydgoszcz, Poland
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.